ThermoGenesis Holdings Inc (THMO)
0.345
-0.04 (-9.26%)
USD |
NASDAQ |
May 20, 16:00
0.35
0.00 (0.00%)
After-Hours: 20:00
ThermoGenesis Holdings Cash from Financing (Quarterly): 0.00 for Dec. 31, 2021
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 6.832M |
| December 31, 2020 | 5.258M |
| September 30, 2020 | 0.356M |
| June 30, 2020 | 6.675M |
| March 31, 2020 | 5.133M |
| December 31, 2019 | 0.103M |
| September 30, 2019 | 1.019M |
| June 30, 2019 | 0.766M |
| March 31, 2019 | 2.311M |
| December 31, 2018 | -0.016M |
| September 30, 2018 | 0.614M |
| June 30, 2018 | 4.80M |
| March 31, 2018 | 1.713M |
| September 30, 2017 | 1.431M |
| June 30, 2017 | 1.998M |
| March 31, 2017 | 1.465M |
| December 31, 2016 | -0.023M |
| September 30, 2016 | 1.934M |
| June 30, 2016 | -0.024M |
| March 31, 2016 | 8.16M |
| December 31, 2015 | -0.013M |
| September 30, 2015 | 4.701M |
| Date | Value |
|---|---|
| June 30, 2015 | -0.053M |
| March 31, 2015 | -0.04M |
| December 31, 2014 | -0.041M |
| September 30, 2014 | -0.055M |
| June 30, 2014 | 10.06M |
| March 31, 2014 | 5.815M |
| December 31, 2013 | 0.00 |
| September 30, 2013 | -0.068M |
| June 30, 2013 | -0.003M |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | -0.054M |
| June 30, 2012 | |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.00 |
| June 30, 2011 | -0.019M |
| March 31, 2011 | 3.932M |
| December 31, 2010 | 0.007M |
| September 30, 2010 | -0.001M |
| June 30, 2010 | -0.001M |
| March 31, 2010 | -0.001M |
| December 31, 2009 | -0.001M |
| September 30, 2009 | -0.001M |
| June 30, 2009 | -0.002M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.016M
Minimum
Dec 2018
6.832M
Maximum
Mar 2021
2.166M
Average
1.225M
Median
Cash from Financing (Quarterly) Benchmarks
| Savara Inc | -0.001M |
| Catalyst Pharmaceuticals Inc | -1.551M |
| Cyclacel Pharmaceuticals Inc | -0.05M |
| Geron Corp | 0.00 |
| Immunogen Inc | 0.62M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.326M |
| Cash from Investing (Quarterly) | -0.029M |
| Free Cash Flow | -6.713M |
| Free Cash Flow Per Share (Quarterly) | -0.0298 |
| Free Cash Flow to Equity (Quarterly) | -1.263M |
| Free Cash Flow Yield | -165.0% |